SRPT - SRPT LOSS ALERT: ROSEN A LEADING INVESTOR RIGHTS LAW FIRM Encourages Sarepta Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – SRPT | Benzinga
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Sarepta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=20094 or call Phillip Kim, Esq. toll-free at 866-767-3653 ...